J. Simón

903 total citations · 1 hit paper
23 papers, 667 citations indexed

About

J. Simón is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, J. Simón has authored 23 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 10 papers in Immunology and 4 papers in Genetics. Recurrent topics in J. Simón's work include Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). J. Simón is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). J. Simón collaborates with scholars based in Mexico, United States and Australia. J. Simón's co-authors include Rubén Burgos‐Vargas, Javier Cabiedes, J Granados, Laura Flores, Yelda A. Leal, Juan R. Velázquez, Javier Torres, Roberto Cedillo‐Rivera, Marí­a Elena Soto and Maité Vallejo and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of the Neurological Sciences and Annals of Emergency Medicine.

In The Last Decade

J. Simón

23 papers receiving 639 citations

Hit Papers

Filgotinib versus placebo or adalimumab in patients with ... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Simón Mexico 14 412 248 116 105 86 23 667
A. Lamour France 16 257 0.6× 308 1.2× 66 0.6× 144 1.4× 30 0.3× 31 642
D Carthy United Kingdom 16 584 1.4× 477 1.9× 106 0.9× 252 2.4× 88 1.0× 23 1.1k
Eleonora Ballanti Italy 12 266 0.6× 357 1.4× 121 1.0× 55 0.5× 62 0.7× 18 649
Charles Mackworth‐Young United Kingdom 13 379 0.9× 279 1.1× 183 1.6× 242 2.3× 28 0.3× 30 660
Z Awdeh United States 8 157 0.4× 448 1.8× 162 1.4× 108 1.0× 60 0.7× 14 726
Shuji Ohta Japan 12 221 0.5× 147 0.6× 92 0.8× 42 0.4× 47 0.5× 24 586
A.H.L. Fielder United Kingdom 15 393 1.0× 601 2.4× 172 1.5× 184 1.8× 59 0.7× 23 893
Tetsushi Aita Japan 9 307 0.7× 480 1.9× 135 1.2× 74 0.7× 30 0.3× 15 844
Stephen R. Holdsworth Australia 9 147 0.4× 449 1.8× 68 0.6× 39 0.4× 58 0.7× 9 806
R I Fox United States 7 131 0.3× 190 0.8× 77 0.7× 93 0.9× 25 0.3× 8 517

Countries citing papers authored by J. Simón

Since Specialization
Citations

This map shows the geographic impact of J. Simón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Simón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Simón more than expected).

Fields of papers citing papers by J. Simón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Simón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Simón. The network helps show where J. Simón may publish in the future.

Co-authorship network of co-authors of J. Simón

This figure shows the co-authorship network connecting the top 25 collaborators of J. Simón. A scholar is included among the top collaborators of J. Simón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Simón. J. Simón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Combe, Bernard, Alan Kivitz, Yoshiya Tanaka, et al.. (2021). Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial. Annals of the Rheumatic Diseases. 80(7). 848–858. 163 indexed citations breakdown →
2.
Genovese, Mark C., Janie Parrino, Anju Garg, et al.. (2016). FRI0228 Sarilumab Dose Reduction To Manage Laboratory Abnormalities in An Open-Label Extension Study in RA Patients. Annals of the Rheumatic Diseases. 75. 515–516. 2 indexed citations
3.
Boatright, Dowin, J. Simón, Christopher W. Woods, et al.. (2015). 167 Factors Important to Underrepresented Minority Applicants When Selecting an Emergency Medicine Program. Annals of Emergency Medicine. 66(4). S59–S60. 4 indexed citations
4.
Kennedy, William P., J. Simón, Ann Herman, et al.. (2014). Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study). Arthritis Research & Therapy. 16(5). 467–467. 40 indexed citations
5.
Guzmán, Renato, Ricardo Machado Xavier, J. Simón, et al.. (2013). Open-Label Observation of Addition of Etanercept Versus a Conventional Disease-Modifying Antirheumatic Drug in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy in the Latin American Region. JCR Journal of Clinical Rheumatology. 20(1). 25–33. 37 indexed citations
6.
Leal, Yelda A., Roberto Cedillo‐Rivera, J. Simón, et al.. (2011). Utility of Stool Sample–based Tests for the Diagnosis of Helicobacter pylori Infection in Children. Journal of Pediatric Gastroenterology and Nutrition. 52(6). 718–728. 61 indexed citations
7.
Stone, L., June Halper, J. Simón, et al.. (2009). FP14-TU-01 Consortium of multiple sclerosis centers (CMSC) guidelines for a standardized MRI protocol for the diagnosis and follow-up of multiple sclerosis: 2009 revision. Journal of the Neurological Sciences. 285. S78–S79. 2 indexed citations
8.
Simón, J., et al.. (2008). Effect of the vehicle on the topical itraconazole efficacy for treating corneal ulcers caused by Aspergillus fumigatus. Clinical and Experimental Ophthalmology. 36(4). 335–338. 6 indexed citations
9.
Simón, J. & Rubén Burgos‐Vargas. (2008). Vitiligo Improvement in a Patient with Ankylosing Spondylitis Treated with Infliximab. Dermatology. 216(3). 234–235. 39 indexed citations
10.
Rojas‐Serrano, Jorge, et al.. (2008). Menor incidencia de daño grave en órganos diana en pacientes mexicanos con esclerosis sistémica con afección cutánea difusa. Reumatología Clínica. 4(1). 3–7. 6 indexed citations
11.
Rojas‐Serrano, Jorge, et al.. (2008). Lower Incidence of Severe Damage to Target Organs in Mexican Patients With Systemic Sclerosis and Diffuse Skin Affection. Reumatología Clínica (English Edition). 4(1). 3–7. 2 indexed citations
12.
Soto, Marí­a Elena, et al.. (2005). Gender impact in systemic lupus erythematosus.. PubMed. 22(6). 713–21. 52 indexed citations
13.
Simón, J., Jorge Rojas‐Serrano, Javier Cabiedes, & Jorge Alcocer‐Varela. (2004). Antinucleosome antibodies may help predict development of systemic lupus erythematosus in patients with primary antiphospholipid syndrome. Lupus. 13(3). 177–181. 16 indexed citations
15.
Simón, J., et al.. (2002). Serum hyperviscosity syndrome responding to therapeutic plasmapheresis in a patient with primary Sjögren's syndrome. Journal of Clinical Apheresis. 17(1). 44–46. 13 indexed citations
16.
Richaud‐Patín, Yvonne, et al.. (2002). Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study. Joint Bone Spine. 69(3). 307–311. 18 indexed citations
17.
Simón, J.. (2002). [Biological therapy in rheumatoid arthritis].. PubMed. 53(5). 452–9. 6 indexed citations
18.
Simón, J., et al.. (1971). Application of the Sterile-Insect-Release Technique in Mediterranean Fruit Fly1Suppression. Journal of Economic Entomology. 64(3). 708–713. 18 indexed citations
19.
Simón, J. & L. C. Helper. (1970). Ocular Disease Associated with Blastomycosis in Dogs. Journal of the American Veterinary Medical Association. 157(7). 922–925. 13 indexed citations
20.
Carroll, John M. & J. Simón. (1967). Eosinophilic granuloma in a dog.. PubMed. 150(5). 526–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026